Vincerx Pharma Investor Relations Material
Latest events
Study Update
Vincerx Pharma
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Vincerx Pharma Inc
Access all reports
Vincerx Pharma Inc. is a clinical-stage biopharmaceutical company engaged in the development of therapies designed to address unmet medical needs in cancer treatment. Their research focuses on creating new treatment options through the development of drugs like enitociclib, a cyclin-dependent kinase-9 inhibitor currently in clinical trials for patients with hematologic malignancies. Another key area of their research involves VIP236, a small molecule drug conjugate, also in trials, targeting solid tumors. Additionally, Vincerx Pharma is exploring product candidates such as VIP943 and VIP924 for treating hematologic malignancies. The company is headquartered in Palo Alto, California, and its shares are listed on the Nasdaq.
Latest articles
)
Lowe's Companies: Building a One-Stop Shop for Home Improvement
Lowe's Companies began as a single store in 1921 and has steadily expanded its footprint and offerings, now operating 1,750 stores across the U.S.
7 May 2025
)
Greg Abel: Succeeding Warren Buffett at Berkshire Hathaway
After decades working with Warren Buffett and Charlie Munger, Greg Abel was named Buffett’s successor as he steps down in late 2025.
5 May 2025
)
Intuitive Surgical: Enhancing Surgery with Robotic Precision
Intuitive Surgical has revolutionized surgery with robotics, building its dominant position through decades of innovation, validation, and expansion.
2 May 2025
Ticker symbol
VINC
Country
🇺🇸 United States